Baxter International (NYSE: BAX ) is expected to report Q4 earnings on Jan. 24. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Baxter International's revenues will increase 3.4% and EPS will grow 7.7%.
The average estimate for revenue is $3.72 billion. On the bottom line, the average EPS estimate is $1.26.
Last quarter, Baxter International reported revenue of $3.48 billion. GAAP reported sales were 0.1% lower than the prior-year quarter's $3.48 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.14. GAAP EPS of $1.06 for Q3 were 5.0% higher than the prior-year quarter's $1.01 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 52.1%, 120 basis points better than the prior-year quarter. Operating margin was 22.3%, 90 basis points better than the prior-year quarter. Net margin was 16.8%, 20 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $14.17 billion. The average EPS estimate is $4.53.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 631 members out of 663 rating the stock outperform, and 32 members rating it underperform. Among 221 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 216 give Baxter International a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Baxter International is outperform, with an average price target of $62.93.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Baxter International. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Baxter International to My Watchlist.